An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples
Authors:
- Dagfinn EkseDEDagfinn Ekse
- Hildegunn HelleHHHildegunn Helle
- Nhat Kim DuongNDNhat Kim Duong
- Per Eystein LønningPLPer Eystein Lønning
- 1 March 2008
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 109 (1-2) , 90-95
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Aromatase Inhibition: Translation into a Successful Therapeutic ApproachClinical Cancer Research, 2005
- Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancerAnnals of Oncology, 2003
- Sources of estrogen and their importanceThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinomaCancer, 2001
- Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer GroupJournal of Clinical Oncology, 2001
- Re: Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 1999
- A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of GuernseyBritish Journal of Cancer, 1997
- Estrogen and bone: New pieces to the puzzleNature Medicine, 1996
- Serum Sex Hormone Levels After Menopause and Subsequent Breast CancerJNCI: Journal of the National Cancer Institute, 1996
- A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 1995